aldosterone has been researched along with 4,5,6,7-tetrabromobenzimidazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grieb, P; Kazimierczuk, Z; Kowalewicz-Kulbat, M; Lawnicka, H; Sicinska, P; Stepien, H | 1 |
1 other study(ies) available for aldosterone and 4,5,6,7-tetrabromobenzimidazole
Article | Year |
---|---|
Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Antineoplastic Agents; Benzimidazoles; Casein Kinase II; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dehydroepiandrosterone Sulfate; Drug Screening Assays, Antitumor; Humans; Hydrocortisone; Protein Kinase Inhibitors | 2010 |